Rankings
▼
Calendar
VRCA (Verrica Pharmaceuticals Inc.) Stock Financials & Earnings | Market Cap Arena
VRCA
Verrica Pharmaceuticals Inc.
Mkt Cap
$56M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$31M
Net Income (TTM)
-$26M
EPS (TTM)
-$3.45
Free Cash Flow (TTM)
-$29M
Gross Margin
91.9%
Op. Margin
-53.2%
Net Margin
-84.4%
FCF Margin
-94.4%
P/S Ratio (TTM)
1.8x
P/E Ratio (TTM)
—
YoY Rev Growth
+234.7%
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Next: Q4 2025 · Mar 11
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$68K
-$3M
-$6M
Q1 23
$37K
-$31K
-$7M
Q2 23
$182K
$46K
-$12M
Q3 23
$3M
$3M
-$24M
Q4 23
$2M
-$19M
-$23M
Q1 24
$4M
$3M
-$19M
Q2 24
$5M
$5M
-$15M
Q3 24
-$2M
-$2M
-$21M
Q4 24
$344K
-$281K
-$11M
Q1 25
$3M
$3M
-$8M
Q2 25
$13M
$12M
$2M
Q3 25
$14M
$13M
$2M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
6.2x
—
Q1 23
6.5x
—
Q2 23
6.6x
—
Q3 23
17.6x
—
Q4 23
11.0x
—
Q1 24
6.3x
—
Q2 24
4.1x
—
Q3 24
6.1x
—
Q4 24
7.5x
—
Q1 25
7.9x
—
Q2 25
3.8x
—
Q3 25
1.8x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$5M
-$5M
Q1 23
-$5M
-$5M
Q2 23
-$5M
-$5M
Q3 23
-$15M
-$15M
Q4 23
-$15M
-$15M
Q1 24
-$20M
-$20M
Q2 24
-$16M
-$16M
Q3 24
-$9M
-$9M
Q4 24
-$16M
-$16M
Q1 25
-$13M
-$13M
Q2 25
-$10M
-$10M
Q3 25
$10M
$10M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$66K
Q1 23
$11K
Q2 23
$59K
Q3 23
$65K
Q4 23
$227K
Q1 24
$0
Q2 24
$11K
Q3 24
$16K
Q4 24
$0
Q1 25
$0
Q2 25
$0
Q3 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
—
-25.9%
Q1 23
-91.4%
-9.1%
Q2 23
-15.0%
+26.4%
Q3 23
-64.9%
+290.5%
Q4 23
+2823.5%
+300.1%
Q1 24
+10240.5%
+214.7%
Q2 24
+2744.5%
+72.8%
Q3 24
-161.1%
-29.5%
Q4 24
-82.7%
-53.2%
Q1 25
-10.1%
-48.4%
Q2 25
+145.4%
-45.1%
Q3 25
+905.4%
-32.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$1M
1722.1%
Q1 23
$1M
2956.8%
Q2 23
$2M
848.4%
Q3 23
$10M
331.3%
Q4 23
$2M
104.4%
Q1 24
$2M
54.2%
Q2 24
$2M
43.0%
Q3 24
$2M
—
Q4 24
$756K
219.8%
Q1 25
$1M
29.8%
Q2 25
$888K
7.0%
Q3 25
$718K
5.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q4 22
$3M
$14M
—
—
Q1 23
$3M
$4M
—
—
Q2 23
$6M
$6M
—
—
Q3 23
$7M
$20M
—
—
Q4 23
$5M
$17M
$4K
—
Q1 24
$5M
$15M
$2M
—
Q2 24
$3M
$15M
$1M
—
Q3 24
$2M
$15M
$1M
—
Q4 24
$1M
$6M
$4M
—
Q1 25
$2M
$9M
$300K
—
Q2 25
$2M
—
—
$9M
Q3 25
$2M
—
—
$9M
marketcaparena.com
Revenue Segments
Collaboration
Product
License And Collaboration Revenue
Quarter
Collaboration
Product
License And Collaboration Revenue
Q3 23
$125K
$3M
—
Q1 24
$594K
$3M
—
Q2 24
$285K
$5M
—
Q4 24
$29K
$315K
—
Q1 25
$17K
$3M
—
Q2 25
—
$5M
$8M
Q3 25
—
$4M
$11M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$34M
$0
$34M
Q1 23
$60M
$0
$60M
Q2 23
$55M
$0
$55M
Q3 23
$84M
$0
$84M
Q4 23
$70M
$0
$70M
Q1 24
$49M
$0
$49M
Q2 24
$32M
$0
$32M
Q3 24
$23M
$0
$23M
Q4 24
$46M
$0
$46M
Q1 25
$30M
$0
$30M
Q2 25
$15M
$0
$15M
Q3 25
$21M
$0
$21M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
4M
-8.0%
Q1 23
4M
+4.7%
Q2 23
5M
+6.7%
Q3 23
5M
+0.3%
Q4 23
5M
+0.5%
Q1 24
5M
+0.4%
Q2 24
5M
+0.0%
Q3 24
5M
+0.7%
Q4 24
7M
+43.8%
Q1 25
9M
+40.9%
Q2 25
9M
+0.1%
Q3 25
9M
-0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 16
—
—
FY 17
—
—
FY 18
$0
16
FY 19
$0
17
FY 20
$0
29
FY 21
$316K
38
FY 22
$411K
22
FY 23
$51K
100
FY 24
$107K
71
marketcaparena.com